Authors

• Hanguo Guo
• Jing Ying Tan (ORCID: https://orcid.org/0000-0002-4605-4624)
• Yi-Chen Sun (ORCID: https://orcid.org/0000-0002-3247-0774)
• Choon Kiat Ong (ORCID: https://orcid.org/0000-0001-6402-4288)
• Diwen Pang
• Yan Teng (ORCID: https://orcid.org/0000-0003-3817-6696)
• Wenyu Li (ORCID: https://orcid.org/0000-0002-8907-7893)
• Fen Zhang (ORCID: https://orcid.org/0000-0002-9978-2035)
• Ling Huang (ORCID: https://orcid.org/0000-0002-5373-7394)

Institutions

• Sun Yat-sen University (CN)
• Duke-NUS Medical School (SG)
• National Cancer Centre Singapore (SG)
• Guangdong Academy of Medical Sciences (CN)
• Sun Yat-sen University Cancer Center (CN)
• Guangdong Provincial People's Hospital (CN)
• Southern Medical University (CN)
• South China University of Technology (CN)

Publication Details

Journal

Frontiers in Immunology

Published

2025-11-28

DOI

https://doi.org/10.3389/fimmu.2025.1683550

Citations

1

Primary Topic

PI3K/AKT/mTOR signaling in cancer

Type

article

Field-Weighted Citation Impact

0.81

Funders

• National Natural Science Foundation of China
• Guangdong Medical Research Foundation
• Guangdong Provincial People's Hospital